Counseling Deaf and Hard-of-Hearing Clients

Author(s):  
Barrie Morganstein

This chapter focuses on developing a clinical practice with Deaf and Hard-of-Hearing individuals. Providing therapeutic services to this specialized population requires knowledge and training in many areas. While the linguistic implications are most obvious, clinicians must also take into account assistive technology, legal and ethical issues, and cultural identity, to name only a few. The author, a psychologist who has trained and practiced extensively with these individuals, describes her practice with this population, including training for, building, and marketing this niche. Developing a practice that understands and meets the needs of deaf and hard-of-hearing individuals can be challenging and rewarding. The chapter also provides a list of resources.

2021 ◽  
pp. 147775092110341
Author(s):  
Mojtaba Vaismoradi ◽  
Cathrine Fredriksen Moe ◽  
M Flores Vizcaya-Moreno ◽  
Piret Paal

The administration of pro re nata medications is the responsibility of the nurse. However, ethical uncertainties often happen due to the inability of incapacitated patients to collaborate with the nurse in the process of decision making for pro re nata medication administration. There is a lack of integrative knowledge and insufficient understanding regarding ethical considerations surrounding the administration of pro re nata medications to incapacitated patients. Therefore, they have been discussed in this paper and practical strategies to avoid unethical practices have been suggested. The complicated caring situation surrounding the administration of pro re nata medications is intertwined with ethical issues affecting the consideration of the patient's wishes and interventions that override them. The patient's right of autonomy and treatment refusal, surrogacy role, paternalism, and coercion are the main ethos of ethical pro re nata medication administration. Education and training can help nurses avoid legal and ethical issues in pro re nata medicines management and improve the quality and safety of healthcare. Empirical research is needed to improve our understanding of this phenomenon in the multidisciplinary environment of medicines management.


Author(s):  
Hazel Biggs

‘Do not attempt resuscitation (DNAR)’ or ‘do not attempt cardiopulmonary resuscitation (DNACPR)’ orders have been regarded as the best way to ensure that patients are not resuscitated in clinically inappropriate circumstances, or against their wishes. However, the use of DNAR orders has become contentious in situations where individuals have not been informed or consulted before an order has been made, and recent legal cases have highlighted the need for good communication and record keeping. This chapter considers the legal and ethical issues associated with DNAR and DNACPR orders, including the rights of patients, ethical guidance and policies associated with their use, and regional and national variations in practices surrounding their use and implementation. After discussing evidence of misinterpretation and misunderstandings of the implications of such orders in clinical practice, which have an impact on patients’ autonomy and well-being, the chapter will conclude that compliance with ethical and professional guidance must be consistent and mandatory, and suggest the introduction of legal sanctions for non-compliance.


2021 ◽  
Author(s):  
David R Bright ◽  
Natasha Petry ◽  
Eric Roath ◽  
Tyler Gibb

Opioid misuse and mismanagement has been a public health crisis for several years. Pharmacogenomics (PGx) has been proposed as another tool to enhance opioid selection and optimization, with recent studies demonstrating successful implementation and outcomes. However, broad engagement with PGx for opioid management is presently limited. The purpose of this Perspective is to highlight a series of barriers to PGx implementation within the specific context of opioid management. Areas of advancement needed for more robust pharmacogenomic engagement with opioids will be discussed, including clinical and economic research needs, education and training needs, policy and public health considerations, as well as legal and ethical issues. Continuing efforts to address these issues may help to further operationalize PGx toward improving opioid use.


2007 ◽  
Vol 7 ◽  
pp. 236-245
Author(s):  
Dennis Ocholla

The purpose of this paper is to re-examine Indigenous Knowledge (IK) in order to suggest an agenda for its development and integration with other forms of knowledge. The paper discusses what marginalization of IK mean, examines the challenges of integrating IK in the mainstream of other forms of knowledges and sug-gests agenda for IK development. The suggested agenda focuses on mapping and auditing IK capacity in Africa, legal and ethical issues, IK management, IK education and training, integration of IK and KM, IK brain drain. The paper recommends that information on IK be widely shared for evaluation, use and further devel-opment.


Author(s):  
Laurie Ehlhardt Powell ◽  
Tracey Wallace ◽  
Michelle ranae Wild

Research shows that if clinicians are to deliver effective, evidence-based assistive technology for cognition (ATC) services to clients with acquired brain injury (ABI), they first need opportunities to gain knowledge and experience with ATC assessment and training practices (O'Neil-Pirozzi, Kendrick, Goldstein, & Glenn, 2004). This article describes three examples of train the trainer materials and programs to address this need: (a) a toolkit for trainers to learn more about assessing and training ATC; (b) a comprehensive, trans-disciplinary program for training staff to provide ATC services in a metropolitan area; and (c) an overview of an on-site/online training package for rehabilitation professionals working with individuals with ABI in remote locations.


2018 ◽  
Vol 49 (3) ◽  
pp. 205-219 ◽  
Author(s):  
Robert L. Glueckauf ◽  
Marlene M. Maheu ◽  
Kenneth P. Drude ◽  
Brittny A. Wells ◽  
Yuxia Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document